Effects of Recombinant Human Erythropoietin on Patient Survival Rate during Severe Sepsis
Recruiting
- Conditions
- Sepsis AnemiaErythropoietinSepsisSurvival rate
- Registration Number
- TCTR20201022004
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1.Participants who admitted to intensive care unit due to sepsis/ septic shock.
2.Participants who age of 18 years or older with received erythropoietin according to their underlying disease.
Exclusion Criteria
1. Participants with missing clinical and laboratory data.
2. Participants who have been referred to another hospital.
3. Participants who have been treated with alternate to standard sepsis bundle scheme for sepsis and/or septic shock treatment as described in sepsis management guidelines.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method